Akzo Nobel Valuation

Is 0A00 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0A00 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0A00 (€58.98) is trading below our estimate of fair value (€139.7)

Significantly Below Fair Value: 0A00 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0A00?

Other financial metrics that can be useful for relative valuation.

0A00 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.3x
Enterprise Value/EBITDA11x
PEG Ratio1.5x

Price to Earnings Ratio vs Peers

How does 0A00's PE Ratio compare to its peers?

The above table shows the PE ratio for 0A00 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average26.8x
CRDA Croda International
32.3x16.0%UK£5.3b
JMAT Johnson Matthey
24.1x28.4%UK£2.6b
VCT Victrex
24.4x37.8%UK£750.5m
TET Treatt
26.5x15.3%UK£299.4m
0A00 Akzo Nobel
17.7x12.0%€10.0b

Price-To-Earnings vs Peers: 0A00 is good value based on its Price-To-Earnings Ratio (17.7x) compared to the peer average (26.8x).


Price to Earnings Ratio vs Industry

How does 0A00's PE Ratio compare vs other companies in the European Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a27.7%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a27.7%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 0A00 is good value based on its Price-To-Earnings Ratio (17.7x) compared to the European Chemicals industry average (17.8x).


Price to Earnings Ratio vs Fair Ratio

What is 0A00's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0A00 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.7x
Fair PE Ratio17.3x

Price-To-Earnings vs Fair Ratio: 0A00 is expensive based on its Price-To-Earnings Ratio (17.7x) compared to the estimated Fair Price-To-Earnings Ratio (17.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0A00 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€58.98
€73.47
+24.6%
10.5%€91.00€58.00n/a19
Oct ’25€62.48
€73.53
+17.7%
12.6%€91.00€54.00n/a19
Sep ’25€57.64
€72.89
+26.5%
13.6%€91.00€53.00n/a18
Aug ’25€56.70
€73.06
+28.8%
13.3%€91.00€53.00n/a18
Jul ’25€55.79
€75.94
+36.1%
13.4%€94.00€53.00n/a18
Jun ’25€63.86
€78.28
+22.6%
9.7%€94.00€65.00n/a18
May ’25€61.95
€78.39
+26.5%
9.8%€94.00€65.00n/a18
Apr ’25€69.17
€78.64
+13.7%
10.7%€96.00€63.00n/a18
Mar ’25€67.76
€79.08
+16.7%
9.7%€96.00€65.00n/a18
Feb ’25€71.08
€79.61
+12.0%
10.9%€96.00€65.00n/a19
Jan ’25€74.88
€79.05
+5.6%
13.2%€100.00€60.00n/a19
Dec ’24€70.46
€79.42
+12.7%
13.2%€100.00€60.00n/a19
Nov ’24€63.25
€80.89
+27.9%
12.0%€100.00€60.00€58.9619
Oct ’24€68.49
€83.29
+21.6%
8.6%€94.00€68.50€62.4819
Sep ’24€75.25
€82.82
+10.1%
10.1%€100.00€68.50€57.6419
Aug ’24€77.15
€82.61
+7.1%
10.1%€100.00€68.50€56.7019
Jul ’24€74.61
€82.21
+10.2%
11.0%€100.00€63.00€55.7919
Jun ’24€71.41
€80.33
+12.5%
15.6%€100.00€42.52€63.8620
May ’24€74.89
€79.20
+5.8%
15.5%€100.00€42.52€61.9520
Apr ’24€71.99
€76.60
+6.4%
16.5%€100.00€42.52€69.1720
Mar ’24€69.44
€76.68
+10.4%
16.4%€100.00€42.52€67.7620
Feb ’24€68.78
€75.58
+9.9%
16.6%€100.00€42.52€71.0820
Jan ’24€63.15
€78.79
+24.8%
18.3%€110.00€42.52€74.8821
Dec ’23€67.78
€78.79
+16.2%
18.4%€110.00€42.52€70.4621
Nov ’23€62.95
€78.99
+25.5%
19.0%€110.00€42.83€63.2521

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies